Development and validation of a prognostic prediction model for alpha-fetoprotein-negative hepatocellular carcinoma with microvascular invasion after surgery
World Journal of Gastroenterology · 2027-01-14 · 33 (2)
DOI: 10.3748/wjg.123092 ↗Abstract
BACKGROUND Microvascular invasion (MVI) is widely recognized as a key factor associated with poor prognosis in hepatocellular carcinoma. Patients with alpha-fetoprotein (AFP)-negative hepatocellular carcinoma (AFP-NHCC) who also have MVI represent a distinct subgroup in which postoperative survival is particularly difficult to predict. AIM To develop and validate a postoperative prognostic scoring system for predicting survival in AFP-NHCC with MVI patients. METHODS This study included clinical data from patients with AFP-NHCC and MVI who underwent surgical treatment. Independent predictors of overall survival (OS) were identified using Cox proportional hazards regression analysis. A prognostic scoring model was constructed based on these independent factors. The model performance was assessed using the concordance index, calibration curves, and decision curve analysis. RESULTS A total of 251 patients were assigned to training (n = 135) and validation (n = 116) cohorts. Univariate and multivariate Cox proportional hazards regression analyses identified tumor burden score, geometric mean of gamma-glutamyl transpeptidase and white blood cell, and neutrophil-to-lymphocyte ratio as independent prognostic factors for OS in the training cohort. A TGN scoring system based on tumor burden score, gamma-glutamyl transpeptidase and white blood cell and neutrophil-to-lymphocyte ratio was subsequently constructed and exhibited good discriminative performance in both the training and validation cohorts, with area under the curve values of 0.816 (95% confidence interval: 0.745-0.887) and 0.807 (95% confidence interval: 0.727-0.885), respectively. Patients were stratified into three risk groups based on TGN scores. Kaplan-Meier analyses revealed significant differences in OS and disease-free survival among the three risk groups. CONCLUSION The TGN model provides an effective tool for individualized postoperative risk stratification in patients with AFP-NHCC and MVI, and may be used to guide postoperative management and surveillance strategies.
EUVIMED